1.026 - 1.050 of 57.639
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 354,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,82x
- Analysis
- Johnson & Johnson Put 140,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 14,23x
- Analysis
- Apple Call 244,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 24,74x
- Analysis
- Toll Brothers Call 170,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- -
- Analysis
- Novo Nordisk Call 342,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,71x
- Analysis
- Novo Nordisk Call 328,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,40x
- Analysis
- Novo Nordisk Call 298,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,20x
- Analysis
- Novo Nordisk Call 286,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,03x
- Analysis
- Novo Nordisk Call 322,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,23x
- Analysis
- Novo Nordisk Call 346,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,79x
- Analysis
- Novo Nordisk Call 336,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,57x
- Analysis
- Novo Nordisk Call 312,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,33x
- Analysis
- Novo Nordisk Call 316,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,15x
- Analysis
- Novo Nordisk Call 272,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,72x
- Analysis
- Novo Nordisk Call 318,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,20x
- Analysis
- Johnson & Johnson Put 180,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 13,80x
- Analysis
- Novo Nordisk Call 306,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,90x
- Analysis
- Johnson & Johnson Put 160,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 17,61x
- Analysis
- Toll Brothers Call 130,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- -
- Analysis
- Novo Nordisk Call 338,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,70x
- Analysis
- Johnson & Johnson Put 180,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 16,45x
- Analysis
- Amazon.com Call 242,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 22,35x
- Analysis
- Johnson & Johnson Put 120,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 12,11x
- Analysis
- Johnson & Johnson Put 140,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 13,74x
- Analysis
- Novo Nordisk Call 326,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,53x
- Analysis